In this article, contact allergy to, and the chemical composition of, tea tree oil (TTO) are reviewed. This essential oil is a popular remedy for many skin diseases, and may be used as neat oil or be present in cosmetics, topical pharmaceuticals and household products. Of all essential oils, TTO has caused most (published) allergic reactions since the first cases were reported in 1991. In routine testing, prevalences of positive patch test reactions have ranged from 0.1% to 3.5%. Nearly 100 allergic patients have been described in case reports and case series. The major constituents of commercial TTO are terpinen-4-ol, -terpinene, 1,8-cineole, -terpinene, -terpineol, p-cymene, and -pinene. Fresh TTO is a weak to moderate sensitizer, but oxidation increases its allergenic potency. The major sensitizers appear to be ascaridole, terpinolene, -terpinene, 1,2,4-trihydroxymenthane, -phellandrene, and limonene. The clinical picture of allergic contact dermatitis caused by TTO depends on the products used. Most reactions are caused by the application of pure oil; cosmetics are the culprits in a minority of cases. Patch testing may be performed with 5% oxidized TTO. Co-reactivity to turpentine oil is frequent, and there is an overrepresentation of reactions to fragrance mix I, Myroxylon pereirae, colophonium, and other essential oils. 
branchlets by steam distillation, has been reported to have multiple biological activities, such as bactericidal, antiviral, antifungal, anti-inflammatory, anti-tumoral, analgesic, insecticidal and acaricidal activities (3) (4) (5) (6) (7) . It is seen by many as a remedy for several skin diseases, including acne, eczema, skin infections such as herpes simplex and warts, wounds, burns, insect bites, dandruff (8) , and nail mycoses (9) . It is marketed as a 'natural' topical antimicrobial (its antimicrobial effects are well documented) and anti-inflammatory agent (10, 11) . In a monograph by the European Medicines Agency (12) , TTO was considered to be suitable for the treatment of small superficial wounds and insect bites, small boils ('furuncles and mild acne'), itching and irritation in cases of athlete's foot, and minor inflammation of the oral mucosa (12) . The product is present in many different formulations, including pure oil, ointments, wart paint (13) , acne treatments (14, 15) , and household products such as fabric softeners, detergents, and cleansers (11, 16, 17) . The oil is also used in many types of cosmetic products (10, 11, 17) , and in aromatherapy for skin diseases, diseases of the respiratory system (e.g. asthma, bronchitis, sinusitis, tuberculosis, and whooping cough), genitourinary diseases (candidiasis, vaginitis, cystitis, and genital pruritus), fever, and infectious diseases such as colds, influenza, and chickenpox (18) .
TTO is sold to the public in diluted, highly concentrated, and undiluted forms. However, as products with high concentrations and, especially, aged (oxidized) oils may induce allergic reactions, the European Cosmetics Association COLIPA recommended in 2002 that TTO should not be used in cosmetic products in a way that results in a concentration greater than 1% oil being applied to the skin. Moreover, manufacturers were advised to consider the use of antioxidants and/or specific packaging to minimize exposure to light (19) . Useful reviews on various aspects of TTO have been published previously (5, 6, 10, 12, 16, 17, (20) (21) (22) (23) (24) .
Chemical Composition
TTO is a colourless to pale yellow, clear mobile liquid that has a terpeny, coniferous and minty-camphoraceus odour. The yield of essential oil from the leaves with terminal branches of M. alternifolia generally varies from 1.0% to 1.8%. The main country producing this oil is Australia; minor quantities come from China, South Africa, and Vietnam. The chemical composition of TTOs may be extremely variable, depending on parameters such as biomass used (from wild or cultivated trees; only leaves or leaves plus terminal branchlets), chemotype (see below), and mode of production (commercial steam distillation Numbers are concentrations in % (wt/wt). versus preparation by hydrodistillation in the laboratory with a Clevenger-type apparatus).
Chemotypes of TTO
Various plant species are known to have several so-called 'chemotypes'. A clear and widely accepted definition for this well-known phenomenon is lacking. In practice, however, it means that, within a population of one plant species with the same morphological features, groups exist with different compositions of their secondary plant products. This is probably regulated by one or only a few genes (25) . The oils produced from the various genotypes are qualitatively very similar; that is, they contain the same spectrum of chemicals, but there are major differences in the quantities of one or several of these. Thus, a specific chemical may be absent or present in trace quantities in one chemotype, and be the dominant component in concentrations of >50% in another. Currently, six chemotypes of M. alternifolia leaf oil are commonly distinguished (Table 1) .
There is an obvious terpinen-4-ol chemotype (type 1), an obvious terpinolene chemotype (type 2), and an (6, (25) (26) (27) , which is an extremely fast-growing tree and a constantly renewable source of oil (28) . The minimum and maximum allowed concentrations of the major components of commercial TTO are shown in -pinene (1.8-9.2%), -phellandrene (trace-5.2%), and -terpineol (1.9-4.2%). The very high concentration of 45.7% for terpinolene was found in one sample from China only; the median terpinolene value for all oils was 3.1%. These data clearly show that not all essential oils can be expected to comply with ISO criteria. The number of identified ingredients is relatively small, as trace constituents (<0.02%), which are not important to the producers and buyers of essential oils, were not quantified and not mentioned in the oils' profiles.
Chemical composition of TTOs from various sources (literature data)
We reviewed the literature on the chemical composition of TTOs up to 11 September 2014 (2), and found nearly (33) . Most samples were (probably) fresh, but some investigators have analysed aged (oxidized) oils (33, 37, 38) . In the TTOs analysed in these studies, over 220 chemicals have been identified. Approximately 55% of these were found in a single reviewed publication only. The compounds that have been found in any study in a concentration of 1% or higher are shown in Table 4 . The chemicals that were identified in most samples include (highest concentrations in any study given) 1,8-cineole (64.1%), terpinen-4-ol (53.7%), terpinolene (45.6%), p-cymene (35.3%), -terpinene (23.2%), -terpinene (12.9%), and -terpineol (11.8%). Well-known ingredients of TTOs that were present in high concentrations (>7%) in one or two studies only were -phellandrene (12.2%) and limonene (7.9%). A rare constituent of TTO found in a high concentration (>7%) in a single study is 2-phenethyl alcohol (15.3%). Full literature data are presented in reference 2. It should be realized that some studies were poorly designed or performed, and that incorrect identifications, especially with trace constituents and certainly in older studies (when analytical methods were far from perfect), are most likely not rare.
Effect of ageing on the composition of TTOs
The composition of TTO changes, particularly in the presence of atmospheric oxygen, but also when the oil is exposed to light, humidity, and higher temperatures. Under these conditions, the antioxidants -terpinene, -terpinene and terpinolene are oxidized to p-cymene. Consequently, the levels of -terpinene, -terpinene and terpinolene decrease, whereas the level of p-cymene increases up to 10-fold (33, 39) . Hence, the concentration of p-cymene is a good measure of the oxidative degradation of TTO (38) . Oxidation processes also lead to the formation of peroxides, endoperoxides and epoxides such as ascaridole (40) . With increasing age, the oil develops a green-brownish colour, the viscosity changes, and the smell becomes turpentine-like. Finally, long thin needles composed of 1,2,4-trihydroxymenthane crystallize (33, 39, 41) .
Contact Allergy/Allergic Contact Dermatitis
Contact allergy to, and allergic contact dermatitis caused by, TTO have been reported frequently. In fact, of all essential oils, TTO has caused most (published) allergic reactions since the first cases were reported in 1991 from Australia, where TTO is produced (1) . There are many reports of routine testing; TTO 5% has been part of the screening series of the North American Contact Dermatitis Group (NACDG) since 2003. In groups of consecutive patients suspected of having contact dermatitis, prevalences of up to 3.5% positive patch test reactions have been observed. Undiluted TTO, products with high concentrations and formulations containing 5% TTO can also, possibly depending on the vehicle, induce irritation of the skin/irritant contact dermatitis (10) . In this section, data on routine testing, data on patch testing with TTO in groups of selected patients, published case reports, the clinical picture of allergic contact dermatitis caused by TTO, the allergens and patch test procedures are reviewed.
Testing in groups of patients

Routine testing
We found 18 investigations in which consecutive patients suspected of having contact dermatitis were tested with TTO, performed or published between 1997 and 2013. In the more recent ones, the usual test concentration was 5% pet., but, in earlier studies, higher concentrations (up to 100%) were used, i.e., concentrations that are now known to have a high risk of inducing irritant reactions. Most recent investigations were performed by the NACDG. The results of routine testing are shown in Table 5 .
Rates of positive reactions have ranged from 0.1% to 3.5%. The highest rates were observed in the Australian studies: 1.8% (51), 2.5% (45, 57) , and 3.5% (45) . In the NACDG studies (United States and Canada), frequencies ranged from 0.9% to 1.4% (mean 1.1%; median 1.0%) (43, 44, 46, 48, 50) . Only two non-Australian studies had scores higher than 2%, one from the United States (47) and the other from the United Kingdom (54) . In the US investigation, 2.1% of routinely tested patients reacted to TTO 5%, but many reactions consisted of macular erythema or were weak, and these were counted as positive (47) . In the study performed in the United Kingdom, 13 of 550 patients (2.4%) reacted to pure, oxidized TTO, which bears a great risk of false-positive reactions. Indeed, the authors reported a staggering 38% irritant patch test reactions to the test substance (54) .
Relevance
In an Australian study, the patch test reactions to TTO of 17 of 41 (41%) patients were considered to be relevant (51) . Only 4 of these 17 patients (24%) had used cosmetic products containing TTO (soap, hand cream, face cream, deodorant, and hand lotion; one product each). Two-thirds of the 41 positively reacting patients recalled prior use of TTO, and 20% specified application of neat (100%) TTO (51) . In a study of the German Contact Dermatitis Research Group (Germany and Austria), the positive patch test reactions of 20 patients of 36 (56%) were considered to be relevant (56) . These patients had used TTO-containing topical products in the (recent) past, leading to blistering and oozing eruptions at the site of application. All had shown ++ or +++ patch test reactions. The other 16, in which relevance was uncertain or absent, had all had a + patch test reaction to TTO only. The causative topical products were not specified (56) .
In the NACDG studies, the sum of 'definite' and 'probable' relevance ranged from 20% to 56%; in these studies, no causative products were mentioned (43, 44, 46, 48) . In one NACDG study, no relevance data were provided (59).
Both cosmetics (including self-made products) containing TTO and pure oil were causative products in several other studies (53, 54, 58) . Occupational allergic contact dermatitis was also reported (54) .
Testing in groups of selected patients
In five studies performed between 1996 and 2014, TTO was patch tested in groups of selected patients. Selection criteria included suspicion of cosmetic dermatitis (60), patient-reported cutaneous reactions to products (notably cosmetics) containing botanical ingredients (61) , and previous reactivity to ascardidole, a known allergen in TTO (42) . The results are shown in Table 6 .
The prevalence of reactions to TTO ranged from 1.6% (61) to 41% (60) . In the latter study, an early investigation from the United Kingdom, 7 of 17 patients (41%) suspected of having cosmetic dermatitis had a positive patch test reaction to TTO. This unrealistically high percentage can probably be explained by the fact that the patients were tested with pure TTO, which is known to cause many irritant patch test reactions (54) . Nevertheless, of these 7 patients, 5 specifically recalled the use of products containing TTO, and a further patient may have been exposed to the oil via aromatherapy (60) .
Case reports
Many case reports and case series on allergic contact dermatitis caused by TTO have been reported; details are shown in Table 7 .
At least 90 allergic patients have been described. Of the cases in which the products responsible for the allergic reactions were specified, approximately two-thirds were related to pure TTO applied for therapeutic purposes for a variety of skin conditions, including acne, eczema, sunburn, wounds (of any cause), warts, herpes, and fungal infections. There were also some cases caused by topical pharmaceutical preparations containing TTO. Six (51) and (53); data provided in Table 5 ]. Products with low concentrations of TTO appear to induce contact allergy or elicit allergic reactions infrequently. Indeed, of 27 cases of contact dermatitis caused by products with TTO that were reported to the Swedish Medicinal Products Agency, all had a TTO concentration of 2% or higher (91) . Nevertheless, the use of shampoos containing TTO may cause eyelid dermatitis in previously sensitized individuals (71).
Positive patch test reactions
In some articles, patients with allergic contact dermatitis caused by other sources co-reacted to TTO; either this had no relevance, or the relevance was not mentioned or was uncertain. Because of the abundance of other literature on TTO, these articles are not specifically mentioned here.
Clinical picture of allergic contact dermatitis caused by TTO
In the majority of cases of sensitization, contact allergy/allergic contact dermatitis is caused by the application of pure oil, usually for therapeutic purposes. This results in localized allergic contact dermatitis at the site of application, which may often be blistering and oozing (56) . It may either stay limited or spread, sometimes all over the body (75) . The clinical picture of reactions to TTO in cosmetics depends on the product used. The dermatitis is usually less severe, because of lower concentrations of the allergen in the cosmetic products and application to intact skin. Examples include periorbital/eyelid dermatitis caused by soap, cream, and shampoo (65, 71) , dermatitis of the beard area caused by shaving oil (65), dermatitis of the face caused by face cream (51), and dermatitis of the face and hands caused by hand lotion (51) . Stomatitis has resulted from contact allergy to TTO in a toothpaste (72) . There are several reports of allergic contact dermatitis caused by occupational exposure, for example in aromatherapists (75, 86) , a beauty therapist/beautician (54, 89) , complementary therapists (54, 66) , and a pedicurist (89) . In the majority, the hands and/or forearms were affected (54, 66, 86, 89) . 
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Ten patients had used pure oil for skin disorders such as eczema, warts, sunburn, and herpes (n = 9), and for 'hygiene and cosmetic purposes (n = 1); 1 patient developed dermatitis from shampoo to which pure oil had been added; no data for the other five cases (80) Allergic contact dermatitis resembling folliculitis barbae (65), erythema multiforme-like contact dermatitis (id) (78) and systemic contact dermatitis after oral administration (90) have rarely been reported. Airborne allergic contact dermatitis caused by inhalation of aqueous solution of TTO has been observed (85) , and may be expected with the use of aromatherapy lamps. In 1 patient, contact allergy induced by pure oil on a piercing wound may have precipitated linear IgA disease (74) . The majority of patients with allergic contact dermatitis caused by TTO were women.
The allergens in TTO
TTO has been extensively investigated. Its sensitizing potential has been shown in both human and animal experiments. Fresh TTO is a weak (80, 88) to moderate (10, 88, (92) (93) (94) sensitizer, but oxidation increases its sensitizing potency (80) . Skin sensitization may also be enhanced by irritancy (10) . Oil stored in open bottles or in a bottle opened several times undergoes an ageing process. Alterations of the components because of oxidative reactions lead to the formation of peroxides, endoperoxides, and epoxides, usually present in very low amounts, formed by the oxidation of terpinen-4-ol and -terpinene (95) . These chemicals are strong sensitizers (39, 80, 96) . Knight and Hausen, in 1994 , were the first to look for the sensitizers in TTO by testing allergic patients with a number of the oil's ingredients (88) . Of 7 allergic patients, 6 (86%) had positive patch test reactions to limonene, 5 (71%) to -terpinene and to aromadendrene, 2 (29%) to terpinen-4-ol, and 1 (14%) to p-cymene and to -phellandrene (88) . Since then, German investigators in particular have tested a considerable number of patients allergic to TTO with one ingredient, a few ingredients or a battery of its constituents to identify the main sensitizers. The results are shown in Table 8 , in which the number of patients allergic to TTO, the test concentration of the oil, and the components reacting in patch testing, with their test concentrations, number of positive reactions, and percentage of positive reactions, are summarized. The results for each individual component in the group of 11 relevant studies (including negative reactions) are shown in Table 9 .
The most frequently reacting sensitizers in TTO appear to be ascaridole, terpinolene, -terpinene [and its oxidation products (96)], 1,2,4-trihydroxymenthane, -phellandrene, and limonene (Table 9 ). Other chemicals that may be responsible for TTO allergy, albeit less frequently (<16%), include myrcene, aromadendrene, D-carvone, L-carvone, terpinen-4-ol, viridiflorene, and, rarely (<5%), sabinene, 1,8-cineole, and p-cymene. The TTO components -pinene, -pinene, -terpinene and -terpineol have thus far not been identified as sensitizers in TTO (Table 9 ). It should be appreciated, however, that, with the exception of -pinene, these chemicals have been tested in a only few patients allergic to TTO. Most of the sensitizers have been found in low concentrations or not at all in commercial TTOs; for some (e.g. ascaridole, which is formed during the oxidation of TTO, and 1,2,4-trihydroxymenthane, which is formed during the ageing process), this can be explained by the fact that these were fresh oil samples (Table 4) .
Most positive patch test reactions to TTO are probably result from sensitization to the oil itself. However, in some cases, they may possibly reflect prior sensitization to an ingredient of the oil. Thus, of 14 patients with occupational contact dermatitis caused by D-limonene who were patch tested with TTO 5% pet., 5 (36%) had a positive (n = 4) or doubtful positive (n = 1) reaction to TTO, although they denied having prior contact with it. This may indicate that previous contact allergy to limonene can result in a positive patch test reaction to TTO (59) . In line with this, some authors have suggested that reactions to limonene may be the result of presensitization to fragrances, rather than being caused by the use of TTO (80) .
Patch testing with TTO
Indication
Patch testing with TTO is indicated when the history of the patient suggests an allergic reaction to the oil or products containing it. In the majority of cases, this will probably be the pure oil, as neither the history nor the clinical picture will alert the clinician to reactions to TTO in, for example, cosmetics, pharmaceutical products, or household products. Preferably, the TTO-containing product used by the patient should be patch tested at a dilution of 5-10% TTO in an appropriate vehicle such as pet. Concentrations up to 25% may have little irritancy potential (92) , but the use of higher concentrations may result in extreme patch test reactions.
Oxidized TTO 5% in pet. is available as a patch test substance from Chemotechnique (www.chemotechnique.se) and from Allergeaze (www.allergeaze.com). The prevalence of positive reactions to TTO in consecutive patients in most countries does not warrant its addition to the baseline series. In Australia, however, inclusion seems to be indicated, and has, indeed, recently been recommended (45) , as routine testing has yielded frequencies of sensitization ranging from 1.8% to 3.5% (45, 51, 57) . It is unknown whether the inclusion of TTO in any additional series will frequently result in unsuspected currently relevant positive patch test reactions, but this is doubtful. Of Terpinolene 5% DEP, n = 17 (85%); ascaridole 5% DEP, n = 15 (75%); -terpinene 5% DEP, n = 16 (80%); 1,2,4-trihydroxymenthane 5% pet., n = 13 (65%); -phellandrene 5% DEP, n = 7 (35%); D-limonene 5% DEP, n = 11 (55%); myrcene 5% DEP, n = 7 (35%); viridiflorene 5% DEP, n = 1 (5%); D-carvone 5% DEP, n = 4 (20%); L-carvone 5% DEP, n = 4 (20%); aromadendrene 5% DEP, n = 1 (5%); sabinene 5% DEP, n = 2 (10%); terpinen-4-ol 5% DEP, n = 1 (5%) (53) 2000, Germany 8 (20% olive oil) Terpinolene 10% aq., n = 7 (88%); ascaridole (5% aq.), n = 7 (88%); -terpinene 5% aq., n = 6 (75%); -phellandrene 5% aq., n = 5 (63%); 1,2,4-trihydroxymenthane 5% pet., n = 2 (25%); D-carvone (5% aq.), n = 1 (13%); terpinen-4-ol 10% aq., n = 1 (13%) (79) 2000, Germany 15 (test concentration/vehicle not specified)
All were tested with 1,2,4-dihydroxymenthane, and 11 (73%) reacted positively (39) 1999-2000, Germany and Austria 10 (5% DEP) Terpinolene 10% DEP, n == 10 (100%); ascaridole 5% DEP, n = 10 (100%); -terpinene 5% DEP, n = 10 (100%); 1,2,4-trihydroxymenthane 5% DEP, n = 9 (90%); -phellandrene 5% DEP, n = 6 (60%); D-limonene 5% DEP, n = 4 (40%); myrcene 5% DEP, n = 1 (10%); viridiflorene 5% DEP, n = 1 (10%) (56) 1999, Germany 16 (test vehicle not mentioned) a
Terpinolene 10%, n = 16 (100%); ascaridole 5%, n = 12 (75%); -terpinene 5%, n = 11 (69%); 1,2,4-trihydroxymenthane 5%, n = 8 (50%); -phellandrene 5%, n = 5 (31%); myrcene 5%, n = 2 (13%); D-limonene 5%, n = 1 (6%); viridiflorene 5%, n = 1 (6%) (80) -Terpinene, n = 1; 3 patients reacted to a sesquiterpenoid hydrocarbon fraction and sesquiterpenoid mixed with paraffin to obtain a concentration as in 25% tea tree oil (92, 93) 1994, Germany 7 (1% solution) D-Limonene 1% ethanol, n = 6 (86%); -terpinene 1% ethanol, n = 5 (71%); aromadendrene 1% ethanol, n = 5 (71%); terpinen-4-ol 1% and 5% ethanol, n = 2 (29%); p-cymene 1% ethanol, n = 1 (14%); -phellandrene 1% ethanol, n = 1 (14%) (88) 1992, The Netherlands
DEP, diethyl phthalate. a Test concentrations were probably in DEP for all allergens except 1,2,4-trihydroxymenthane, which was tested in pet. (53) .
the ingredients of TTO that have caused contact allergy, only limonene and carvone are available as commercial patch test materials. For testing with the important sensitizer ascaridole, a test concentration of 2% has been recommended (42) . Higher concentrations may reveal more cases of sensitization, but also result in some 10% doubtful and 10% irritant reactions (42) .
Co-reactivity
Oil of turpentine. There appears to be frequent co-reactivity to oil of turpentine in patients reacting to TTO. The German Contact Dermatitis Research Group tested 3375 consecutive patients suspected of having contact dermatitis in 1999 and 2000 in 11 clinics in Germany and Austria (56) . There were 36 (1.1%) positive reactions to TTO. Fourteen of these patients (39%) co-reacted to oil of turpentine 10% pet., which is part of the baseline series in these countries (56) . In another German study (80) , concomitant reactions to oil of turpentine were seen in 7 of 16 (44%) patients allergic to TTO, and co-reactivity was also observed in a case report (73) . A commercial oil of turpentine test substance used by the members of the German Contact Dermatitis Research Group contained 72% -pinene, 15% -pinene, 5% dipentene (limonene), 2% caryophyllene, 1% camphene, 1% myrcene, 1% longifolene, 0.1% carenes, and 3% unidentified components, with a peroxide degree of 30% (98). Ingredients of these preparations that have been found as sensitizers in TTO include limonene and myrcene (Table 9 ). In the second half of the 1990s, a sudden increase in the prevalence of positive patch test reactions to oil of turpentine was noticed (98) . It has been suggested that this can partly be explained by primary TTO sensitization (56) , oil of turpentine reacting to common allergenic ingredients, or cross-reacting substances. Indeed, of 16 turpentine-positive patients who denied contact with turpentine, and who were tested with their own TTO preparations, 10 (63%) showed positive patch test reactions to TTO (98) .
Other co-reacting substances. In patients allergic to TTO, co-reactions to fragrance mix I (58, 66, 75, 80, 85, 86, 89) , Myroxylon pereirae (balsam of Peru) (66, 75, 78, 80, 89) , colophonium (rosin) (58, 74, 75, 78-80, 85, 87, 89) and one or more essential oils (56, 66, 75, 76, 80, 85, 86, 89) have been observed regularly. Although there appears to be an overrepresentation, the data are insufficient to show whether the frequencies of co-reactivity are significantly increased, and, if so, whether they are attributable to concomitant sensitization, cross-reactivity, or pseudo-cross-reactivity (common allergenic ingredients). However, the association between TTO and oil of turpentine reactions seems to be clear (∼40% co-reactivity to oil of turpentine (56, 80) . In turn, turpentine-sensitive patients react significantly more frequently to the fragrance mix (46% of the patients versus 9.4% of turpentine-negative patients), to Myroxylon pereirae (29% versus 7% of turpentine-negative patients), and to colophonium (23% versus 3% of turpentine-negative patients) (98) .
In a group of 12 patients reacting to compound tincture of benzoin [benzoin 10%, aloe 2%, styrax 8%, Myroxylon balsamum (balsam of Tolu) 4% in 95% ethanol], 5 (42%) co-reacted to TTO. The number of TTO-allergic patients who also reacted to compound tincture of benzoin was not mentioned (57) . Co-reactivity to TTO in a tincture of benzoin-sensitive patient was also mentioned in (99) . An aromatherapist allergic to TTO and many other essential oils also reacted to benzoin (86) .
